28.03.2024 12:06:41 - dpa-AFX: *GILEAD SCIENCES, XILIO THERAPEUTICS ANNOUNCE LICENSE AGREEMENT TO DEVELOP TUMOR-ACTIVATED IL-12 PROGRAM, XTX301

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
GILEAD SCIENCES DL-,001 885823 Xetra 64,980 27.06.24 09:30:09 -0,230 -0,35% 64,630 64,880 64,870 65,210

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH